As of Thursday, March 05, Century Therapeutics, Inc.’s IPSC share price has surged by 5.97%, which has investors questioning if this is right time to sell.
In February 2026, XellSmart Pharmaceutical Co., Ltd. (XellSmart) announced that it had secured its fourth US FDA and China NMPA clearance for Phase I/II registrational clinical trial entry with its ...
2026年2月19日,日本厚生劳动省药事审议会作出一项历史性建议:对两款基于诱导多能干细胞(iPSC)的再生医疗产品给予“附条件及期限批准”。 如果后续行政程序顺利完成,它们将成为全球首批真正迈入商业化临床应用的iPSC技术。
Mayo IPSC will be represented at a national 'Drop Allianz' demonstration to coincide with the annual GAA Congress this Saturday.
BioLife Solutions has executed a successful turnaround by refocusing on core products and divesting non-core assets. Read ...
Tenaya Therapeutics, Inc. TNYA shares are up on Thursday, reflecting a positive market response to a research collaboration agreement with Alnylam Pharmaceuticals Inc. ALNY. • Tenaya Therapeutics ...
近日,中源协和细胞基因工程股份有限公司旗下子公司——协和干细胞基因工程有限公司自主研发和申报的诱导多能干细胞(iPSC)(Vcanbio Induced Pluripotent Stem Cells),先后获得美国药监局(FDA)下属药品评价与研究中心(CDER)及生物制品评价与研究中心(CBER)的药物主文件(DMF ...
Pomodoro timers are a simple productivity tool. They help you work in dedicated chunks of time, usually 25 minutes in a sitting, before taking a short break and then beginning again. [Clovis Fritzen] ...
The International Society for Cell & Gene Therapy (ISCT), the translation-focused global community of cell and gene therapy experts and the Japanese Society for Regenerative Medicine (JSRM), advancing ...
Induced pluripotent stem cell technology is a promising, rapidly evolving field with the potential to transform cell-based therapeutics across a range of disease areas that have significant unmet ...
Market expansion in med derm cross over: Almirall’s Seysara (sarecycline) won NMPA approval for moderate to severe acne (≥9 years), with China commercial launch targeted for 2026 – relevant to ...
这两款产品分别用于治疗重症心力衰竭(ReHeart)和帕金森病(Amchepri),标志着全球首个iPSC来源细胞产品获得药事审批,诺贝尔奖得主山中伸弥教授2006年的开创性研究,历经二十年终于从实验室迈入产业化阶段。
一些您可能无法访问的结果已被隐去。
显示无法访问的结果